BETi-211 manufacturers
- BETi-211
-
- $2180.00
-
2026-05-11
- CAS:1995867-02-1
- Purity:
- Supply Ability: 10g
|
| | BETi-211 Basic information |
| Product Name: | BETi-211 | | Synonyms: | 9H-Pyrimido[4,5-b]indol-4-amine, N-(3-cyclopropyl-1-ethyl-1H-pyrazol-5-yl)-7-(3,5-dimethyl-4-isoxazolyl)-6-methoxy-2-(methoxymethyl)-;BETi-211;BETi211,BETi 211 | | CAS: | 1995867-02-1 | | MF: | C26H29N7O3 | | MW: | 487.55 | | EINECS: | | | Product Categories: | | | Mol File: | 1995867-02-1.mol |  |
| | BETi-211 Chemical Properties |
| | BETi-211 Usage And Synthesis |
| Description | BETi-211 is a novel selective BET bromodomain inhibitor. | | Uses | BETi-211 is an orally active BET inhibitor (Ki: <1 nM). BETi-211 inhibits growth of triple-negative breast cancers (TNBC) cell lines with IC50 < 1 μM. BETi-211 degrades BET proteins and suppress tumor growth in xenograft breast tumors[1]. | | References | [1] Bai L, et al. Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer. Cancer Res. 2017 May 1;77(9):2476-2487. DOI:10.1158/0008-5472.CAN-16-2622 |
| | BETi-211 Preparation Products And Raw materials |
|